227 related articles for article (PubMed ID: 8521452)
1. Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.
Okubo T; Inokuma S; Takeda S; Itoyama S; Kinoshita K; Sugawara I
Cell Biophys; 1995 Jun; 26(3):205-13. PubMed ID: 8521452
[TBL] [Abstract][Full Text] [Related]
2. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.
Arai T; Yamashita T; Urano T; Masunaga A; Itoyama S; Itoh K; Shiku H; Sugawara I
Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649
[TBL] [Abstract][Full Text] [Related]
3. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
4. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
[TBL] [Abstract][Full Text] [Related]
5. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
[TBL] [Abstract][Full Text] [Related]
6. [Expression of CD44V6 and nm23-H1 in thyroid papillary adenocarcinoma and lymph node metastasis].
Wei Q; Fan S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):5-7, 30. PubMed ID: 10681781
[TBL] [Abstract][Full Text] [Related]
7. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
Liu Y; Jiang C; Tan Y
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Lung Cancer; 1999 Apr; 24(1):11-6. PubMed ID: 10403689
[TBL] [Abstract][Full Text] [Related]
9. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
10. Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients.
Tomita M; Ayabe T; Matsuzaki Y; Onitsuka T
Eur J Cardiothorac Surg; 2001 Jun; 19(6):904-7. PubMed ID: 11404150
[TBL] [Abstract][Full Text] [Related]
11. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.
Qian M; Feng Y; Xu L; Zheng S; Zhou X
Chin Med J (Engl); 1997 Feb; 110(2):142-4. PubMed ID: 9594287
[TBL] [Abstract][Full Text] [Related]
12. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
13. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M
Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479
[TBL] [Abstract][Full Text] [Related]
15. Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.
Tomita M; Ayabe T; Matsuzaki Y; Edagawa M; Maeda M; Shimizu T; Hara M; Onitsuka T
BMC Cancer; 2001; 1():3. PubMed ID: 11319942
[TBL] [Abstract][Full Text] [Related]
16. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
Zou M; Shi Y; al-Sedairy S; Farid NR
Br J Cancer; 1993 Aug; 68(2):385-8. PubMed ID: 8394105
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the expression levels of nm23-H1 mRNA in primary breast cancer, benign breast disease, axillary lymph nodes and normal breast tissue.
Goodall RJ; Dawkins HJ; Robbins PD; Hähnel E; Sarna M; Hähnel R; Papadimitriou JM; Harvey JM; Sterrett GF
Pathology; 1994 Oct; 26(4):423-8. PubMed ID: 7892043
[TBL] [Abstract][Full Text] [Related]
18. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
[TBL] [Abstract][Full Text] [Related]
19. [Study on expression of nm23-H1 gene in laryngeal cancer tissues].
Wang Q; Guo M; Sun L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(4):198-200. PubMed ID: 9642340
[TBL] [Abstract][Full Text] [Related]
20. [nm23-H1 protein expression and its clinical significance in human laryngeal carcinoma].
Liang C; Xu G
Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):391-3. PubMed ID: 11387948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
